Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Dietary Supplement Enforcement Procedure Streamlining Planned By CFSAN

This article was originally published in The Tan Sheet

Executive Summary

Consolidating FDA's enforcement process with regard to inappropriate dietary supplement claims is one of the Center for Food Safety & Applied Nutrition's "A-list" goals for 2000.

Related Content

CFSAN Supplement "Disease Claims" Enforcement Authority Spelled Out
Botanicals History Of Use Should Satisfy Food GRAS Requirements - Hutt
Supplement Labeling Safety One Of Six Guidance Topics Raised By GAO
CFSAN program priorities
Ephedrine Alkaloids Dosing, Duration Limits Withdrawn Pending Public Input
Pearson/health claims forum
Infant Formula "With Iron" Statement Is Misleading - Mead Johnson
"Courtesy" Letter Process Under Review At FDA
Supplement AE Monitoring System Would Receive $2.5 Mil. In 2001 Budget
CFSAN 10-Year Dietary Supplement Strategy Comprises Six Core Areas





Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts